OxyContin maker Purdue Pharma cuts remaining sales force

(Reuters) – OxyContin maker Purdue Pharma LP, facing a wave of lawsuits blaming it for helping fuel the U.S. opioid epidemic, said on Wednesday it had laid off about 350 employees this week including the remainder of its already-downsized sales force.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News